Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) has been given a consensus recommendation of “Buy” by the eight ratings firms that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating, two have issued a buy rating and three have given a strong buy rating to the company.
Several equities research analysts have issued reports on RBGLY shares. Barclays downgraded shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 4th. Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th. HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Finally, Royal Bank of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th.
Read Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 0.4 %
Reckitt Benckiser Group Increases Dividend
The business also recently declared a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be issued a $0.2909 dividend. The ex-dividend date of this dividend is Friday, April 11th. This is a boost from Reckitt Benckiser Group’s previous dividend of $0.19.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- Growth Stocks: What They Are, Examples and How to Invest
- FedEx Delivers Another Crushing Blow to Its Stock Price
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Comparing and Trading High PE Ratio Stocks
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.